Treatment Discontinuation Among Patients with Schizophrenia Treated with Brexpiprazole and Other Oral Atypical Antipsychotics in Japan: A Retrospective Observational Study

INTRODUCTION: Treatment continuation is essential for relapse prevention in patients with schizophrenia. The aim of this exploratory study was to compare the time to treatment discontinuation between patients with schizophrenia prescribed brexpiprazole (BRX group) and those prescribed other atypical...

Descripción completa

Detalles Bibliográficos
Autores principales: Hishimoto, Akitoyo, Yasui-Furukori, Norio, Sekine, Daisuke, Matsukawa, Miyuki, Yamada, Sakiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9402511/
https://www.ncbi.nlm.nih.gov/pubmed/35904721
http://dx.doi.org/10.1007/s12325-022-02252-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9402511/
https://www.ncbi.nlm.nih.gov/pubmed/35904721
http://dx.doi.org/10.1007/s12325-022-02252-9

Ejemplares similares